-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $118

Benzinga·05/06/2026 12:48:42
Listen to the news
Wedbush analyst Yun Zhong maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $112 to $118.